These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34716530)

  • 21. A comparison of confidence interval methods for the intraclass correlation coefficient in community-based cluster randomization trials with a binary outcome.
    Braschel MC; Svec I; Darlington GA; Donner A
    Clin Trials; 2016 Apr; 13(2):180-7. PubMed ID: 26415500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cluster randomized clinical trials in orthodontics: design, analysis and reporting issues.
    Pandis N; Walsh T; Polychronopoulou A; Eliades T
    Eur J Orthod; 2013 Oct; 35(5):669-75. PubMed ID: 23041934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cluster randomised trials with different numbers of measurements at baseline and endline: Sample size and optimal allocation.
    Copas AJ; Hooper R
    Clin Trials; 2020 Feb; 17(1):69-76. PubMed ID: 31580144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis.
    Cosby RH; Howard M; Kaczorowski J; Willan AR; Sellors JW
    Fam Pract; 2003 Feb; 20(1):77-82. PubMed ID: 12509376
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Imbalance and Intracluster Correlation Coefficient in Cluster Randomized Trials with Binary Outcomes.
    Ahn C; Hu F; Skinner CS
    Comput Stat Data Anal; 2009 Jan; 53(3):596-602. PubMed ID: 20084091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sample size calculations for intervention trials in primary care randomizing by primary care group: an empirical illustration from one proposed intervention trial.
    Eldridge S; Cryer C; Feder G; Underwood M
    Stat Med; 2001 Feb; 20(3):367-76. PubMed ID: 11180307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials.
    Yang S; Li F; Starks MA; Hernandez AF; Mentz RJ; Choudhury KR
    Stat Med; 2020 Dec; 39(28):4218-4237. PubMed ID: 32823372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs.
    Taljaard M; Teerenstra S; Ivers NM; Fergusson DA
    Clin Trials; 2016 Aug; 13(4):459-63. PubMed ID: 26940696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A note on sample size calculations for cluster randomised crossover trials with a fixed number of clusters.
    Kelly TL; Pratt N
    Stat Med; 2019 Aug; 38(18):3342-3345. PubMed ID: 31069820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Power calculation of adjusted McNemar's test based on clustered data of varying cluster size.
    Wu Y
    Biom J; 2018 Nov; 60(6):1190-1200. PubMed ID: 30288765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracluster correlation coefficients and coefficients of variation for perinatal outcomes from five cluster-randomised controlled trials in low and middle-income countries: results and methodological implications.
    Pagel C; Prost A; Lewycka S; Das S; Colbourn T; Mahapatra R; Azad K; Costello A; Osrin D
    Trials; 2011 Jun; 12():151. PubMed ID: 21672223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sample size determination for stepped wedge cluster randomized trials in pragmatic settings.
    Wang J; Cao J; Zhang S; Ahn C
    Stat Methods Med Res; 2021 Jul; 30(7):1609-1623. PubMed ID: 34139916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sample Size Calculation for Count Outcomes in Cluster Randomization Trials with Varying Cluster Sizes.
    Wang J; Zhang S; Ahn C
    Commun Stat Theory Methods; 2020; 49(1):116-124. PubMed ID: 31768088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.
    Forbes AB; Akram M; Pilcher D; Cooper J; Bellomo R
    Clin Trials; 2015 Feb; 12(1):34-44. PubMed ID: 25475880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation.
    Li F; Tong G
    Biom J; 2021 Jun; 63(5):1052-1071. PubMed ID: 33751620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Information growth for sequential monitoring of clinical trials with a stepped wedge cluster randomized design and unknown intracluster correlation.
    Brown SP; Shoben AB
    Clin Trials; 2020 Apr; 17(2):176-183. PubMed ID: 32026713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and sample size estimation in clinical trials with clustered survival times as the primary endpoint.
    Xie T; Waksman J
    Stat Med; 2003 Sep; 22(18):2835-46. PubMed ID: 12953283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methods for sample size determination in cluster randomized trials.
    Rutterford C; Copas A; Eldridge S
    Int J Epidemiol; 2015 Jun; 44(3):1051-67. PubMed ID: 26174515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
    Fazzari MJ; Kim MY; Heo M
    J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.